Cargando…
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
PURPOSE: To examine factors associated with non-adherence during 5 years of endocrine treatment, including the possible influence of comorbidity burden and specific medical conditions. METHODS: From all women diagnosed with stage I–III, ER-positive breast cancer in Stockholm-Gotland, Uppsala–Örebro...
Autores principales: | Wulaningsih, W., Garmo, H., Ahlgren, J., Holmberg, L., Folkvaljon, Y., Wigertz, A., Van Hemelrijck, M., Lambe, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208918/ https://www.ncbi.nlm.nih.gov/pubmed/30030708 http://dx.doi.org/10.1007/s10549-018-4890-z |
Ejemplares similares
-
Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study
por: Valachis, Antonis, et al.
Publicado: (2016) -
Serum lactate dehydrogenase and survival following cancer diagnosis
por: Wulaningsih, Wahyu, et al.
Publicado: (2015) -
Serum inflammatory markers and colorectal cancer risk and survival
por: Ghuman, Sundeep, et al.
Publicado: (2017) -
Serum Glucose and Fructosamine in Relation to Risk of Cancer
por: Wulaningsih, Wahyu, et al.
Publicado: (2013) -
Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
por: Makubate, B, et al.
Publicado: (2013)